CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $621,540 | +149.4% | 22,813 | +103.7% | 0.13% | +193.0% |
| Q2 2023 | $249,200 | -57.9% | 11,200 | -61.6% | 0.04% | -15.7% |
| Q4 2022 | $591,996 | +87.9% | 29,148 | +137.1% | 0.05% | +168.4% |
| Q3 2022 | $315,000 | -78.2% | 12,293 | -79.8% | 0.02% | -65.5% |
| Q2 2022 | $1,448,000 | +259.3% | 60,889 | +240.2% | 0.06% | +266.7% |
| Q1 2022 | $403,000 | -12.2% | 17,900 | -22.7% | 0.02% | +7.1% |
| Q4 2021 | $459,000 | +31.1% | 23,165 | +57.6% | 0.01% | -33.3% |
| Q1 2021 | $350,000 | -40.4% | 14,700 | -51.6% | 0.02% | -89.1% |
| Q3 2017 | $587,000 | +260.1% | 30,400 | +120.3% | 0.19% | +336.4% |
| Q2 2017 | $163,000 | – | 13,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |